Life Sciences Research Entrepreneur
Scott Thacher has 30 years of experience in life sciences research and pharmaceutical R&D.
Scott is founder and CEO of Orphagen Pharmaceuticals. He led Orphagen to its first strategic partnership in 2008, with JT Pharma. Scott was a founder and the first president of SDEE. He is also on the Board of Io Therapeutics.
Prior to founding Orphagen, Scott directed programs in acne, psoriasis, hyperlipidemia, and diabetes at Allergan and served on its management teams for strategic collaborations in dermatology and diabetes.
Scott was previously on the biochemistry faculty as the Texas A&M College of Medicine (1986-1993) and holds a Ph.D. in biophysics from Harvard University and a B.S. in physics (Stanford).